Skip to content Learn about the access keys available for Aristotle Open Metadata Registry
This item has been superseded by a newer version by one or more Registration Authorities.

Definition

The rate of Staphylococcus aureus (including MRSA) bacteraemia is no more than 2.0 per 10,000 patient days for acute care public hospitals by 2011–12 in each state and territory.

Indicator Summary

Numerator

SAB patient episodes (as defined in computation description) associated with acute care public hospitals.

See more

Denominator

Number of patient days for public acute care hospitals (only for hospitals reporting SAB indicator)

See more
Computation

Acute care public hospitals are defined as all public hospitals including those hospitals defined as public psychiatric hospitals in the Public Hospital Establishment National Minimum Data Set.

A patient-episode of SAB is defined as a positive blood culture for Staphylococcus aureus. For surveillance purposes, only the first isolate per patient is counted, unless at least 14 days has passed …

See more
Disaggregation

2009–10—State and territory, by:

  • Methicillin-resistant Staphylococcus aureus (MRSA)/Methicillin-sensitive Staphylococcus aureus (MSSA)

Disaggregation is subject to data quality considerations. Some disaggregation may result in numbers too small for publication.

See more

Calculation rules

Computation Rule
Description

Acute care public hospitals are defined as all public hospitals including those hospitals defined as public psychiatric hospitals in the Public Hospital Establishment National Minimum Data Set.

A patient-episode of SAB is defined as a positive blood culture for Staphylococcus aureus. For surveillance purposes, only the first isolate per patient is counted, unless at least 14 days has passed without a positive blood culture, after which an additional episode is recorded.

A Staphylococcus aureus bacteraemia will be considered to be healthcare-associated if: the first positive blood culture is collected more than 48 hours after hospital admission or less than 48 hours after discharge, OR, if the first positive blood culture is collected 48 hours or less after admission and one or more of the following key clinical criteria was met for the patient-episode of SAB:

  1. SAB is a complication of the presence of an indwelling medical device (e.g. intravascular line, haemodialysis vascular access, CSF shunt, urinary catheter)
  2. SAB occurs within 30 days of a surgical procedure where the SAB is related to the surgical site
  3. An invasive instrumentation or incision related to the SAB was performed within 48 hours
  4. SAB is associated with neutropenia (<1 x 109) contributed to by cytotoxic therapy

Exclusions:

Cases where a known previous positive test has been obtained within the last 14 days are excluded. For example: If a patient has SAB in which 4 sets of blood cultures are positive over the initial 3 days of the patient’s admission only one episode of SAB is recorded. If the same patient had a further set of positive blood cultures on day 6 of the same admission, these would not be counted again, but would be considered part of the initial patient-episode.

Note: If the same patient had a further positive blood culture 20 days after admission (i.e. greater than 14 days after their last positive on day 5), then this would be considered a second patient-episode of SAB.

Analysis by state and territory is based on location of the hospital.

Presented as a number per 10,000 patient days

Coverage: Denominator ÷ Number of patient days for all public hospitals in the state or territory.

Any variation from the specifications by jurisdictions will be footnoted and described in the data quality statement.

Numerators

SAB patient episodes (as defined in computation description) associated with acute care public hospitals.

Denominators

Number of patient days for public acute care hospitals (only for hospitals reporting SAB indicator)

Disaggregation

2009–10—State and territory, by:

  • Methicillin-resistant Staphylococcus aureus (MRSA)/Methicillin-sensitive Staphylococcus aureus (MSSA)

Disaggregation is subject to data quality considerations. Some disaggregation may result in numbers too small for publication.

References

Related content

Relation Count
Indicator Sets that include this Indicator 0
Data Sets that are used in this Indicator 0